Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| ThyPRO: Pacientu ziņoto iznākumu skala, kas saistīta ar vairogdziedzeri× | AGHDA: Pieaugušo augšanas hormona deficīta novērtējums× | |
|---|---|---|
| Nozare | Endokrinoloģija | Endokrinoloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 2009 | 2000 |
| Autors≠ | Torquil Watt, Jens Bjørner, Marianne Groenvold | Anthony Hunt, Garry Werther, Peter Wrightson |
| Tips | Patient self-report questionnaire | Patient self-report questionnaire |
| Pirmavots≠ | Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580. link ↗ | Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346. link ↗ |
| Citi nosaukumi≠ | ThyPRO-85, ThyPRO-39 | AGHDA-25 |
| Saistītās | 3 | 3 |
| Kopsavilkums≠ | ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer. | The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy. |
| ScholarGateDatu kopa ↗ |
|
|